Automatic Peptide Synthesizer Market Size, Trends, Share, Growth, and Opportunity Forecast, 2024 - 2031 Global Industry Analysis By Type (Fully-Automatic, and Semi-Automatic), By Capacity (Small Scale, and Larger Scale), By Application (Drug Development, Academic Research, Diagnostics, and Therapeutics), By End-user (School Laboratory, Biopharmaceutical Company, Synthesis Services Company, and Research Institutions) and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

The Global Automatic Peptide Synthesizer Market was valued at USD 450.8 Million in 2023 and is anticipated to reach a value of USD 855.5 Million by 2031 expanding at a CAGR of 8.4% between 2024 and 2031.

An automatic peptide synthesizer is a laboratory instrument used to synthesize many peptides simultaneously in a fast and convenient way. This laboratory equipment automates the procedure of synthesizing peptides. Peptides are short chains of amino acids, which are the building blocks of proteins. Peptides are utilized in preparation of epitope-specific antibodies, enzyme binding sites, and map antibody epitopes and to design novel enzymes, drugs, and vaccines. The application of automated peptide synthesizer has played a significant role in all areas of peptide and protein research. Automatic peptide synthesizer is well-known across the world as a preferred choice for providing flexibility and reliability in peptide research. These instruments are employed in various industries, including biotechnology, pharmaceuticals, and research. Peptides play an essential role in drug development, diagnostics, and therapeutics. The market is classified into fully-automatic, and semi-automatic peptide synthesizers. The market is influenced by factors such as increasing use in pharmaceutical drugs, rising demand for peptide therapeutics, growing research and development activities, and increasing prevalence of chronic diseases.

Automatic Peptide Synthesizer Market Major Driving Forces

Increasing Use in Pharmaceutical Drugs: The growth of an automatic peptide synthesizers market is primarily attributed to the growing use of peptides in pharmaceutical drugs. Peptides play a crucial role in drug development due to their therapeutic potential, driving the market growth.

Rising Demand for Peptide Therapeutics: The increasing demand for peptide-based therapeutics which also includes peptide medications and biologics drives the market growth. Peptides are becoming well-known in the biotechnology and pharmaceutical industry due to their benefits such as reduced toxicity, and higher efficiency than conventional small molecule medications.

Growing Research and Development Activities: Another key driver influencing the automatic peptide synthesizer market is the rising research and development activities in the fields of biotechnology, and pharmaceuticals. Researchers are investing in research to explore new peptide-based therapeutics, diagnostics, and biomaterials, creating a growing demand for efficient peptide synthesizers.

Increasing Prevalence of Chronic Diseases: With the growing geriatric population, there is growing risk of chronic diseases. Rising incidences of chronic diseases such as oncology, obesity, diabetes, and cancer are expanding the market growth. Peptides play an essential role in treating these diseases owing to their therapeutic potential.

Automatic Peptide Synthesizer Market Key Opportunities

Growing Focus on Personalized Medicine: The growing emphasis on the development of personalized medicines provides significant growth opportunities for automatic peptide synthesizer market. The significant shift towards personalized medicine and targeted therapies is boosting demand for peptides tailored to individual patient needs.

Digital Transformation: The rapid digital transformation in automatic peptide synthesizer industry creates an opportunity for market expansion. Technological advancements in peptide synthesis such as integrating automated systems, digital platforms, artificial intelligence, and robotics to enhance their efficiency and accuracy.  

Focus on Sustainability and Green Chemistry: There is a growing focus on sustainability and green chemistry in industry, as consumers are increasingly demanding for eco-friendly and sustainable products. Manufacturers can capitalize on this trend by utilizing green chemistry principles, sustainable practices in production, packaging, and distribution.

Automatic Peptide Synthesizer Market Key Trends

·         The growing focus on personalized medicines for treating patients according to their unique genetic and molecular profiles

·         The increasing demand for peptide-based therapeutics due to their specific benefits such as reduced toxicity and higher specificity than conventional small molecule medications

·         The growing interest in peptide-based drugs due to rise in chronic diseases are further propelling market growth

·         The rising need for efficient and high-throughput peptide synthesizers is a significant factor influencing the market growth

·         Technological advancements in peptide synthesis, such as integration of AI, IoT, blockchain, and robotics to enhance efficiency, and accuracy

·         The growing emphasis on developing eco-friendly and sustainable peptide synthesis processes by utilizing sustainable production practices

·         The growing demand for automatic peptide synthesizer that offer customization and flexibility to cater specific requirements

Region-wise Market Insights

North America accounted for the largest market share at 34.7% in 2023 whereas, Asia Pacific is expected to register the fastest growth, expanding at a CAGR of 9.0% between 2024 and 2031.

The North America region currently holds the largest market share for automatic peptide synthesizers. This is due to the presence of major pharmaceutical and biotechnology companies, a well-established healthcare infrastructure, in increasing research and development activities in the region. Furthermore, significant government funding for healthcare and life sciences research, and technological advancements also contributing to the regional market growth. Europe is also a significant market for automatic peptide synthesizers due to growing adoption of peptide therapeutics and strong presence of pharmaceutical and biotechnology companies. In Asia-Pacific, the market is characterized by rising prevalence of chronic diseases, increasing healthcare expenditure, and rise in the investments in biotechnology and life sciences research which has created an increasing demand for automatic peptide synthesizers. The Middle East and Africa has been witnessing a growing demand for automatic peptide synthesizers due to improving healthcare infrastructure whereas, in South America, the market is influenced by economic factors, with government funding in research.

Market Competition Landscape

The global automatic peptide synthesizer market is characterized by high degree of competition among a large number of manufacturers. Prominent companies operating in the market are investing in research and development to introduce innovative products and gain a competitive edge.  Key players in the automatic peptide synthesizer market engage in strategies aimed at gaining a competitive edge. These strategies include product innovation, design differentiation, and the incorporation of sustainable and eco-friendly materials to meet evolving consumer preferences. Established brands leverage their reputation for quality and reliability to maintain market share, while newer entrants focus on disruptive innovations and unique selling propositions.

Key players in the global automatic peptide synthesizer market implement various organic and inorganic strategies to strengthen and improve their market positioning. Prominent players in the market include:

·         Bachem Holding AG

·         AAPPTec.

·         CSBio

·         Biotage

·         GenScript

·         Büchi AG

·         Activotec

·         CEM Corporation

·         Merck KGaA

·         Zealand Pharma A/S

·         Multisyntech GmbH

·         AnaSpec

·         Auspep

·         Biosynth Laboratories Limited

·         LUMITOS AG